Quote:
Originally Posted by suzzer99
Not even sure if it will help. But they've already tried a million other things.
I assume the insurance company doesn't actually pay sticker price. What they actually do pay of course is a closely guarded secret because USA #1 healthcare.
|
Looks like the patent expired march 2021(Europe may 22)hopefully that can make it more affordable , looks like only Ontario/Quebec cover the costs from the 6 year old article I found .
Maybe not
"With a Soliris biosimilar showing up in its rearview mirror, Alexion is piling on patents for its superexpensive drug, hoping to put some more distance between it and any sales-grabbing copies."